Trademark: 88879904
Word
AVEYABEK
Status
Pending
Status Code
734
Status Date
Monday, January 22, 2024
Serial Number
88879904
Mark Type
4000
Filing Date
Monday, April 20, 2020
Published for Opposition
Tuesday, June 1, 2021

Trademark Owner History
Celgene Corporation - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use

Trademark Events
Jan 23, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 22, 2024
Sou Extension 5 Granted
Jan 3, 2024
Sou Extension 5 Filed
Jan 22, 2024
Case Assigned To Intent To Use Paralegal
Jan 3, 2024
Sou Teas Extension Received
Jul 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 13, 2023
Sou Extension 4 Granted
Jul 13, 2023
Sou Extension 4 Filed
Jul 13, 2023
Sou Teas Extension Received
Jan 26, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 24, 2023
Sou Extension 3 Granted
Jan 24, 2023
Sou Extension 3 Filed
Jan 24, 2023
Sou Teas Extension Received
Jul 15, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 13, 2022
Sou Extension 2 Granted
Jul 13, 2022
Sou Extension 2 Filed
Jul 13, 2022
Sou Teas Extension Received
Jan 21, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 19, 2022
Sou Extension 1 Granted
Jan 19, 2022
Sou Extension 1 Filed
Jan 19, 2022
Sou Teas Extension Received
Jul 27, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 1, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 1, 2021
Published For Opposition
May 12, 2021
Notification Of Notice Of Publication E-Mailed
Apr 27, 2021
Approved For Pub - Principal Register
Jan 26, 2021
Notification Of Final Refusal Emailed
Jan 26, 2021
Final Refusal E-Mailed
Jan 26, 2021
Final Refusal Written
Jan 12, 2021
Teas/Email Correspondence Entered
Jan 11, 2021
Correspondence Received In Law Office
Jan 11, 2021
Teas Response To Office Action Received
Jul 14, 2020
Notification Of Non-Final Action E-Mailed
Jul 14, 2020
Non-Final Action E-Mailed
Jul 14, 2020
Non-Final Action Written
Jul 11, 2020
Assigned To Examiner
Apr 29, 2020
New Application Office Supplied Data Entered
Apr 23, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24